Clinician Scientist Development Award in Myasthenia Gravis Grant

Clinician Scientist Development Award in Myasthenia Gravis Grant

Status: ACTIVE
Funder: Myasthenia Gravis Foundation of America
Amount: Up to US $240,000
Last Updated: August 12, 2025

Summary

The Clinician Scientist Development Award in Myasthenia Gravis is a prestigious grant aimed at supporting early-career researchers focused on clinical and translational studies in myasthenia gravis. Funded by the Myasthenia Gravis Foundation of America and the American Brain Foundation, it offers $75,000 per year for three years, along with a $5,000 stipend for education and research costs. This initiative encourages innovative research and the development of new treatments for neurological diseases.

Overview

Clinician Scientist Development Award in Myasthenia Gravis Overview The Clinician Scientist Development Award in Myasthenia Gravis, funded by the MGFA and the American Brain Foundation in collaboration with the American Academy of Neurology, aims to recognize the importance of rigorous clinical and translational research and to encourage young investigators in clinical and translational studies related to myasthenia gravis. This award will consist of a commitment of $75,000 per year for three years, plus a $5,000 per-year stipend to support education and research-related costs, for a total of $240,000.

Eligibility

You can learn more about this opportunity by visiting the funder's website. For the purpose of this scholarship/award, research is defined as “patient-oriented research conducted with human participants, or translational research specifically designed to develop treatments or enhance diagnosis of neurologic disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.Recipient must be interested in an academic career in neurologic research with a MD, PhD or equivalent doctoral-level clinical degree who has completed clinical residency or PhD no more than 7 years to the beginning of this award (July 1, 2026). If you have completed both residency and a PhD, your eligibility is based on when you completed residency.If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency. If you have completed both residency and a PhD, your eligibility is based on when you completed residency. If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency.Applicants at accredited US and international institutions are eligible.The research plan should be written by the applicant and should represent their original work. Supplementation of the award with other grants is permissible.Please only submit one application.In general you do not have to be an American citizen to apply. You do not need to be certified to practice medicine in the US to apply.There are no visa requirements for the grant, so you may apply for the grant with the J1 visa.We accept multiple applications from institutions.As long as the award is not a K (or K equivalent) or an R award and it ends by the start of the AAN funding (June 30th), then you are eligible to apply.If the funding does not end by the start of the AAN funding (June 30th), supplementation of the award with other grants is permissible but it cannot exceed the total annual amount of the AAN award.If you have applied and you did not receive an award, you may reapply next year.Applicants have successfully reapplied and received funding in subsequent years.If you are in the middle of a fellowship when the AAN grant starts, you are still eligible provided that you are able to meet the required 70% protected research time.The award only covers direct costs. Direct costs include: salary; travel to research-related meetings; MRI/CT scans; participation costs; reimbursement for patients; equipment; fringe benefits; tuition; classes; publication costs; research-related personnel (research coordinator, data analysis staff, etc.). You would be eligible if you were to apply this year and still complete advanced postdoctoral work the following year while on the AAN grant, however, note that your chair would still need to sign a letter agreeing that 70 percent of your time would need to be protected for research.Regarding the 70 percent requirement, you should plan to devote 4 full work days perweek to the research activities.Patient care is limited to 30 percent of your time.

Ineligibility

Applicants are not allowed to submit applications for more than one award. To be eligible to apply for this award, the other grant source(s) cannot exceed $80,000 annually.Advance Practice Providers (APPs) are not eligible.The award does not cover indirect costs.Indirect costs include facility and administrative costs and AAN/other neurological society membership dues.